Clinical trial
A Multi-Center, Open Label, Collaborative Research Study to Treat HRS-AKI Patients With Continuous Terlipressin Infusion
NCT04460560 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center, Open Label, Collaborative Research Study to Treat HRS-AKI Patients With Continuous Terlipressin Infusion
- Lead sponsor
- University of Pennsylvania
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 11, 2020
- Completion date
- December 27, 2023
- Enrollment
- 50 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.